Cargando…
An improved route to 19-substituted geldanamycins as novel Hsp90 inhibitors – potential therapeutics in cancer and neurodegeneration
19-Substituted geldanamycin derivatives are efficient Hsp90 inhibitors, without the toxicity associated with the other benzoquinone ansamycins, thus giving them potential for use as molecular therapeutics in cancer and neurodegeneration. Here a new method of synthesising these important compounds is...
Autores principales: | Kitson, Russell R. A., Moody, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835074/ https://www.ncbi.nlm.nih.gov/pubmed/23770604 http://dx.doi.org/10.1039/c3cc43457e |
Ejemplares similares
-
Development of the first geldanamycin-based HSP90 degraders
por: Wurnig, Silas, et al.
Publicado: (2023) -
Synthesis and biological evaluation of geldanamycin–ferulic acid conjugate as a potent Hsp90 inhibitor
por: Li, Zhenyu, et al.
Publicado: (2019) -
HSP90 Inhibitor Geldanamycin as a Radiation Response Modificator in Human Blood Cells
por: Stankova, Katia, et al.
Publicado: (2015) -
A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90
por: Palma, Luana Carneiro, et al.
Publicado: (2019) -
HSP90 Inhibitors, Geldanamycin and Radicicol, Enhance Fisetin-Induced Cytotoxicity via Induction of Apoptosis in Human Colonic Cancer Cells
por: Wu, Ming-Shun, et al.
Publicado: (2013)